Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Moore

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
JAAD Case Reports|September 25, 2025
Delayed but long-term resolution of nevus of Ota after cessation of picosecond 755-nm alexandrite laser treatmentsAngela Moore, An Nguyen, Luke Moore, et al.
JAAD Case Reports|February 7, 2023
Painful facial, oral, and genital ulcersAngela Moore, Kara Hurley, Omar Lupi, et al.
Journal of Cancer Survivorship : Research and Practice|March 4, 2015
An evaluation of cancer survivorship activities across national comprehensive cancer control programsJ Michael Underwood, Naheed Lakhani, Elizabeth Rohan, et al.
Hippocampus|January 28, 2016
Naloxone injections into CA3 disrupt pattern completion associated with relapse from cocaine seekingRaymond P Kesner, Ryan A Kirk, Jascha K Clark, et al.
Cancer|June 13, 2012
Health status of adolescent and young adult cancer survivorsEric Tai, Natasha Buchanan, Julie Townsend, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic MedicationLeon Kircik, Linda Stein Gold, Joyce Teng, et al.
Journal of Drugs in Dermatology : JDD|January 4, 2014
Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label studyAngela Moore, Steven Kempers, George Murakawa, et al.
Journal of the American Academy of Dermatology|November 23, 2006
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasisAngela Moore, Kenneth B Gordon, Sewon Kang, et al.
Preventing Chronic Disease|June 29, 2013
An update on tobacco control initiatives in comprehensive cancer control plansKatherine Dunne, Susan Henderson, Sherri L Stewart, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2013
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studiesJoseph Fowler, Mark Jackson, Angela Moore, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
JAAD Case Reports|September 25, 2025
Delayed but long-term resolution of nevus of Ota after cessation of picosecond 755-nm alexandrite laser treatmentsAngela Moore, An Nguyen, Luke Moore, et al.
JAAD Case Reports|February 7, 2023
Painful facial, oral, and genital ulcersAngela Moore, Kara Hurley, Omar Lupi, et al.
Journal of Cancer Survivorship : Research and Practice|March 4, 2015
An evaluation of cancer survivorship activities across national comprehensive cancer control programsJ Michael Underwood, Naheed Lakhani, Elizabeth Rohan, et al.
Hippocampus|January 28, 2016
Naloxone injections into CA3 disrupt pattern completion associated with relapse from cocaine seekingRaymond P Kesner, Ryan A Kirk, Jascha K Clark, et al.
Cancer|June 13, 2012
Health status of adolescent and young adult cancer survivorsEric Tai, Natasha Buchanan, Julie Townsend, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic MedicationLeon Kircik, Linda Stein Gold, Joyce Teng, et al.
Journal of Drugs in Dermatology : JDD|January 4, 2014
Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label studyAngela Moore, Steven Kempers, George Murakawa, et al.
Journal of the American Academy of Dermatology|November 23, 2006
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasisAngela Moore, Kenneth B Gordon, Sewon Kang, et al.
Preventing Chronic Disease|June 29, 2013
An update on tobacco control initiatives in comprehensive cancer control plansKatherine Dunne, Susan Henderson, Sherri L Stewart, et al.
Journal of Drugs in Dermatology : JDD|July 11, 2013
Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studiesJoseph Fowler, Mark Jackson, Angela Moore, et al.
Pageof 6